|
TARA Protara Therapeutics Inc 1359931 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-21,668,000.00 |
| Balance Sheet |
|
Current Assets
|
$146,152,000.00 |
|
Assets
|
$176,093,000.00 |
|
Current Liabilities
|
$13,319,000.00 |
|
Liabilities
|
$14,782,000.00 |
|
Equity
|
$161,311,000.00 |
|
Shares Out
|
59083935.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-36,732,000.00 |
|
Investing Cash Flow
|
$3,033,000.00 |
| Market Analysis |
Market Cap
|
$230,427,346.50 |
|
Price
|
$3.90 |
|
BVPS
|
2.73 |
|
PB
|
1.43 |
|
EPS
|
-0.36 |
|
FCF
|
$-37,064,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:37 |
|
| Apr |
May |
Jun |
| 2026-03-10 |
-0.37 |
|
|
2026-05-13 |
-0.31 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.35 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.31 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TARA documents filed with the SEC.
TARA Filings
Clear
